Effects of Selective Seratonine Re-Uptake Inhibitors on Meniere’s Disease
Author(s) -
Olcay Kıroğlu,
Özgür Sürmelioğlu,
Mete Kıroğlu
Publication year - 2017
Publication title -
the journal of international advanced otology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.518
H-Index - 13
eISSN - 2148-3817
pISSN - 1308-7649
DOI - 10.5152/iao.2017.3042
Subject(s) - escitalopram , medicine , meniere's disease , vertigo , anxiety , pediatrics , generalized anxiety disorder , amisulpride , magnetic resonance imaging , psychiatry , surgery , radiology , antidepressant , schizophrenia (object oriented programming) , antipsychotic
To evaluate the effects of selective serotonin re-uptake inhibitors (SSRIs) on Meniere's disease (MD) on patients who have both MD and generalized anxiety disorder.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom